GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Susmed Inc (TSE:4263) » Definitions » Research & Development

Susmed (TSE:4263) Research & Development : 円232.9 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Susmed Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Susmed's Research & Development for the three months ended in Dec. 2023 was 円60.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was 円232.9 Mil.


Susmed Research & Development Historical Data

The historical data trend for Susmed's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Susmed Research & Development Chart

Susmed Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Research & Development
86.37 249.14 226.37 176.31

Susmed Quarterly Data
Jun20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.92 52.14 61.62 58.31 60.87

Susmed Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円232.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Susmed  (TSE:4263) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Susmed Research & Development Related Terms

Thank you for viewing the detailed overview of Susmed's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Susmed (TSE:4263) Business Description

Traded in Other Exchanges
N/A
Address
3-7-2, Honcho, Nihombashihoncho, Chuo-ku, Tokyo, JPN, 103-0023
Susmed Inc is engaged in the development of medical equipment and software systems Collection and distribution of medical information.

Susmed (TSE:4263) Headlines

No Headlines